Cholera Vaccines Market Size, Revenue, Growth, Trend & Forecast Analysis, 2020 - 2027, By Product, By End-User, By Country, & By Region

  • Report Id: HCDHR 2373
  • Published Date: August, 2020
  • No of Pages: 150
  • Format: Electronic (PDF)
  • Publisher: DataHorizzon Research
  • Category:

Cholera Vaccines Market Report Overview

Cholera vaccines market garnered a revenue of USD 74.2 million in the year 2019 globally and is anticipated to reach USD 134.8 million by 2027, growing at a compound annual growth (CAGR) of 8.5% (2020-2027). The market has been observed to be growing at a steady growth rate over the last three years, however with the impact of COVID-19 pandemic globally, the business conditions are expected to change. The market size may reduce significantly or increase with a spike depending on how the value chain has been affected in the entire process.

Players that are operational in the market for a longer period of time are anticipated to absorb the sudden changes, losses and increased operational costs better than those who have recently entered the market. The report focuses on numerous factors that are anticipated to impact the market growth directly and indirectly. The report categorically analyses the growth patterns of different segments based on multiple derivation models.

Both the qualitative and quantitative aspects have been covered under the report. The Cholera Vaccines market report includes market size, drivers, restraints, opportunities and trends that will help you understand the market dynamics in detail. Moreover, the report will include market estimates & forecasts in terms of revenue for the overall market along with the segments mentioned in the study. The report focuses on providing a holistic view of the entire market scenario from multiple unmatched detailed analysis mentioned in the report.

What to expect from the report?

  • Cholera Vaccines Total Available Market (TAM) Size
  • Cholera Vaccines Serviceable Available Market (SAM) Size
  • Business Implications of COVID-19 on the Overall Market
  • Market Share/ Revenue Share (%) of Top Market Players in Total Market Size (2019)
  • Market Size & Forecast (2016-2027) At Country & Regional Level, By Segments
  • Overview & Analysis of Key Players Operating in the Market

Key Highlights:

Parameters

Description

COVID-19

Impact of COVID-19 on overall business scenario

Cholera Vaccines Market Revenue 2020

Global market revenue in 2020 will be derived taking into various micro & macro level factors; along with COVID-19 pandemic

Competitive Analysis

Company Market Share Analysis, 2019 (%)

Supply Chain Analysis

Analysis pertaining to several participants of supply chain such as raw material suppliers, distributors, & OEMs along with others will be highlighted in the study

Data Source

Primary & Secondary Research, Internal Data Base & Company Annual Reports

Regions Included

North America, Europe, Asia Pacific, Latin America, & Middle East & Africa

Countries Included

U.S., Canada, U.K., Germany, France, Mexico, Brazil, China, India, Japan, South Korea, UAE, South Africa

Table of Contents
Chapter 1. Research Methodology & Data Sources
1.1. Data Analysis Models
1.2. Research Scope & Assumptions
1.3. List of Primary & Secondary Data Sources
Chapter 2. Executive Summary
Chapter 3. Cholera Vaccines Market: Industry Analysis
3.1. Market segmentation
3.2. Supply chain analysis
3.3. Porter’s 5 forces analysis
3.4. PEST analysis
3.5. Market Dynamics
3.5.1. Market driver analysis
3.5.2. Market restraint analysis
3.5.3. Market opportunity analysis
3.6. Company Market Share Analysis, 2019
Chapter 4. Cholera Vaccines Market: Product Insights
4.1. Global Product Historic Market Data & Future Forecasts, 2016-2027
4.2. Shanchol
4.2.1. Historic Market Data & Future Forecasts, 2016-2027
4.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.3. Dukoral
4.3.1. Historic Market Data & Future Forecasts, 2016-2027
4.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.4. Vaxchora
4.4.1. Historic Market Data & Future Forecasts, 2016-2027
4.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.5. Euvichol & Euvichol-Plus
4.5.1. Historic Market Data & Future Forecasts, 2016-2027
4.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.6. Others
4.6.1. Historic Market Data & Future Forecasts, 2016-2027
4.6.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 5. Cholera Vaccines Market: End-User Insights
5.1. Global End-User Historic Market Data & Future Forecasts, 2016-2027
5.2. Hospitals & clinics
5.2.1. Historic Market Data & Future Forecasts, 2016-2027
5.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.3. Research & Academic Laboratories
5.3.1. Historic Market Data & Future Forecasts, 2016-2027
5.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.4. Others
5.4.1. Historic Market Data & Future Forecasts, 2016-2027
5.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 6. Cholera Vaccines Market: Regional Insights
6.1. Global Cholera Vaccines Market Data & Future Forecasts, By Region 2016-2027
6.2. North America
6.2.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.2.3. Historic Market Data & Future Forecasts, By End-User, 2016-2027
6.2.4. U.S.
6.2.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.4.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.2.4.3. Historic Market Data & Future Forecasts, By End-User, 2016-2027
6.2.5. Canada
6.2.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.5.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.2.5.3. Historic Market Data & Future Forecasts, By End-User, 2016-2027
6.3. Europe
6.3.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.3.3. Historic Market Data & Future Forecasts, By End-User, 2016-2027
6.3.4. U.K.
6.3.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.4.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.3.4.3. Historic Market Data & Future Forecasts, By End-User, 2016-2027
6.3.5. Germany
6.3.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.5.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.3.5.3. Historic Market Data & Future Forecasts, By End-User, 2016-2027
6.3.6. France
6.3.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.6.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.3.6.3. Historic Market Data & Future Forecasts, By End-User, 2016-2027
6.4. Asia Pacific
6.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.4.3. Historic Market Data & Future Forecasts, By End-User, 2016-2027
6.4.4. China
6.4.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.4.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.4.4.3. Historic Market Data & Future Forecasts, By End-User, 2016-2027
6.4.5. India
6.4.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.5.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.4.5.3. Historic Market Data & Future Forecasts, By End-User, 2016-2027
6.4.6. Japan
6.4.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.6.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.4.6.3. Historic Market Data & Future Forecasts, By End-User, 2016-2027
6.4.7. South Korea
6.4.7.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.7.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.4.7.3. Historic Market Data & Future Forecasts, By End-User, 2016-2027
6.5. Latin America
6.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.5.3. Historic Market Data & Future Forecasts, By End-User, 2016-2027
6.5.4. Brazil
6.5.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.4.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.5.4.3. Historic Market Data & Future Forecasts, By End-User, 2016-2027
6.5.5. Mexico
6.5.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.5.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.5.5.3. Historic Market Data & Future Forecasts, By End-User, 2016-2027
6.6. Middle East & Africa
6.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.6.3. Historic Market Data & Future Forecasts, By End-User, 2016-2027
6.6.4. UAE
6.6.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.4.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.6.4.3. Historic Market Data & Future Forecasts, By End-User, 2016-2027
6.6.5. South Africa
6.6.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.5.2. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.6.5.3. Historic Market Data & Future Forecasts, By End-User, 2016-2027
Chapter 7. Company Profiles
7.1. Mitsubishi Tanabe Pharma Corporation
7.1.1. Company Description
7.1.2. Financial Highlights
7.1.3. Product Portfolio
7.1.4. Strategic Initiatives
7.2. AstraZeneca
7.2.1. Company Description
7.2.2. Financial Highlights
7.2.3. Product Portfolio
7.2.4. Strategic Initiatives
7.3. Emergent BioSolutions, Inc.
7.3.1. Company Description
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. Strategic Initiatives
7.4. Pfizer, Inc.
7.4.1. Company Description
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. Strategic Initiatives
7.5. Takeda Pharmaceutical Co., Ltd.
7.5.1. Company Description
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. Strategic Initiatives
7.6. Merck & Co., Inc.
7.6.1. Company Description
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. Strategic Initiatives
7.7. Astellas Pharma, Inc.
7.7.1. Company Description
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. Strategic Initiatives
7.8. PaxVax, Inc.
7.8.1. Company Description
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. Strategic Initiatives
7.9. Valneva SE
7.9.1. Company Description
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. Strategic Initiatives
7.10. Shantha Biotechnics Private Limited
7.10.1. Company Description
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. Strategic Initiatives  
List of Tables
Table 1 Cholera Vaccines Market Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 2 Cholera Vaccines Market Data & Future Forecasts, By Region, 2016-2027 (USD Billion)
Table 3 Cholera Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion)
Table 4 Cholera Vaccines Market Data & Future Forecasts, By End-User, 2016-2027 (USD Billion)
Table 5 Shanchol Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 6 Dukoral Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 7 VaAstraZenecahora Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 8 Euvichol & Euvichol-Plus Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 9 Others Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 10 Hospitals & clinics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 11 Research & Academic Laboratories Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 12 Others Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 13 ] Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 14 North America Cholera Vaccines Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 15 North America Cholera Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion)
Table 16 North America Cholera Vaccines Market Data & Future Forecasts, By End-User, 2016-2027 (USD Billion)
Table 17 U.S. Cholera Vaccines Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 18 U.S. Cholera Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion)
Table 19 U.S. Cholera Vaccines Market Data & Future Forecasts, By End-User, 2016-2027 (USD Billion)
Table 20 Canada Cholera Vaccines Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 21 Canada Cholera Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion)
Table 22 Canada Cholera Vaccines Market Data & Future Forecasts, By End-User, 2016-2027 (USD Billion)
Table 23 Europe Cholera Vaccines Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 24 Europe Cholera Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion)
Table 25 Europe Cholera Vaccines Market Data & Future Forecasts, By End-User, 2016-2027 (USD Billion)
Table 26 U.K. Cholera Vaccines Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 27 U.K Cholera Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion)
Table 28 U.K Cholera Vaccines Market Data & Future Forecasts, By End-User, 2016-2027 (USD Billion)
Table 29 Germany Cholera Vaccines Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 30 Germany Cholera Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion)
Table 31 Germany Cholera Vaccines Market Data & Future Forecasts, By End-User, 2016-2027 (USD Billion)
Table 32 France Cholera Vaccines Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 33 France Cholera Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion)
Table 34 France Cholera Vaccines Market Data & Future Forecasts, By End-User, 2016-2027 (USD Billion)
Table 35 Asia Pacific Cholera Vaccines Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 36 Asia Pacific Cholera Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion)
Table 37 Asia Pacific Cholera Vaccines Market Data & Future Forecasts, By End-User, 2016-2027 (USD Billion)
Table 38 China Cholera Vaccines Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 39 China Cholera Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion)
Table 40 China Cholera Vaccines Market Data & Future Forecasts, By End-User, 2016-2027 (USD Billion)
Table 41 India Cholera Vaccines Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 42 India Cholera Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion)
Table 43 India Cholera Vaccines Market Data & Future Forecasts, By End-User, 2016-2027 (USD Billion)
Table 44 Japan Cholera Vaccines Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 45 Japan Cholera Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion)
Table 46 Japan Cholera Vaccines Market Data & Future Forecasts, By End-User, 2016-2027 (USD Billion)
Table 51 South Korea Cholera Vaccines Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 52 South Korea Cholera Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion)
Table 53 South Korea Cholera Vaccines Market Data & Future Forecasts, By End-User, 2016-2027 (USD Billion)
Table 53 Latin America Cholera Vaccines Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 54 Latin America Cholera Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion)
Table 55 Latin America Cholera Vaccines Market Data & Future Forecasts, By End-User, 2016-2027 (USD Billion)
Table 56 Brazil Cholera Vaccines Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 57 Brazil Cholera Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion)
Table 58 Brazil Cholera Vaccines Market Data & Future Forecasts, By End-User, 2016-2027 (USD Billion)
Table 59 Mexico Cholera Vaccines Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 60 Mexico Cholera Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion)
Table 61 Mexico Cholera Vaccines Market Data & Future Forecasts, By End-User, 2016-2027 (USD Billion)
Table 62 Middle East & Africa Cholera Vaccines Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 63 Middle East & Africa Cholera Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion)
Table 64 Middle East & Africa Cholera Vaccines Market Data & Future Forecasts, By End-User, 2016-2027 (USD Billion)
Table 65 UAE Cholera Vaccines Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 66 UAE Cholera Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion)
Table 67 UAE Cholera Vaccines Market Data & Future Forecasts, By End-User, 2016-2027 (USD Billion)
Table 68 South Africa Cholera Vaccines Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 69 South Africa Cholera Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion)
Table 70 South Africa Cholera Vaccines Market Data & Future Forecasts, By End-User, 2016-2027 (USD Billion)
List of Figures
Fig.1 Data Analysis Model
Fig.2 Cholera Vaccines Market, by 2016-2027 (USD Billion)
Fig.3 Cholera Vaccines Market Segmentation
Fig.4 Supply chain analysis
Fig.5 Cholera Vaccines Market Driver Anlaysis
Fig.6 Cholera Vaccines Market Restraint Analysis
Fig.7 Cholera Vaccines Market Opportunity Analysis
Fig.8 Porters 5 Forces Model
Fig.9 PEST Analysis- Cholera Vaccines Market
Fig.10 Company Market Share Analysis, 2019

Cholera Vaccines Market Segmentation:

Cholera Vaccines Market, By Product (2016-2027)

  • Shanchol
  • Dukoral
  • Vaxchora
  • Euvichol & Euvichol-Plus
  • Others

Cholera Vaccines Market, By End-User (2016-2027)

  • Hospitals & clinics
  • Research & Academic Laboratories
  • Others

Cholera Vaccines Market, By Region (2016-2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • South Africa

Major Players Operating in the Cholera Vaccines Market:

  • Mitsubishi Tanabe Pharma Corporation
  • AstraZeneca
  • Emergent BioSolutions, Inc.
  • Pfizer, Inc.
  • Takeda Pharmaceutical Co., Ltd.
  • Merck & Co., Inc.
  • Astellas Pharma, Inc.
  • PaxVax, Inc.
  • Valneva SE
  • Shantha Biotechnics Private Limited


Choose License Type

Single user
$3,960
Multi User
$4,950
Enterprise User
$5,940
Clear

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements

Max ROI

Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.